The company reported $1.48 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.44 by $0.04. About 118,796 shares traded. It also reduced its holding in Procter And Gamble Co (NYSE:PG) by 6,720 shares in the quarter, leaving it with 21,045 shares, and cut its stake in Motorola Solutions Inc (NYSE:MSI). It has underperformed by 1.71% the S&P500. Jennison Associates LLC bought a new position in AbbVie in the 3rd quarter worth approximately $544,418,000. The firm owned 59,201 shares of the company's stock after selling 8,055 shares during the quarter. The institutional investor held 65,825 shares of the real estate investment trusts company at the end of 2017Q3, valued at $2.37 million, up from 15,715 at the end of the previous reported quarter. Abbvie Inc now has $178.89B valuation. ABBV has diverse figures for different time frames; starting from week's performance it is bestowing negative returns of -4.68% in last five regular trading sessions. (NYSE:ABBV). Braun Stacey Assoc Inc invested 0.25% in AbbVie Inc. It has underperformed by 6.07% the S&P500.
Investors sentiment is 0.83 in Q3 2017. Its up 0.29, from 0.74 in 2017Q2. Opus Inv Management invested in 1.32% or 81,700 shares. 100 funds opened positions while 451 raised stakes. Overbrook reported 36,653 shares. Fenimore Asset Management holds 0.24% or 830,200 shares. 18,300 AbbVie Inc. (NYSE:ABBV) shares with value of $1.66M were sold by Gosebruch Henry O. Pnc Fin Group holds 0% of its portfolio in Evolution Petroleum Corporation (NYSEAMERICAN:EPM) for 330 shares. 1,337 shares were sold by SALEKI-GERHARDT AZITA, worth $157,458. John G Ullman & stated it has 66,898 shares or 1.89% of all its holdings. (NYSE:ABBV). Moreover, Eagle Global Advsr Limited Liability Company has 0.03% invested in AbbVie Inc. Cibc World Markets Inc has 0.68% invested in Apple Inc. 7,550 were reported by Bluefin Trading Limited Company. Canandaigua National Bank & Trust Co. now owns 34,942 shares of the company's stock valued at $2,534,000 after purchasing an additional 582 shares during the period. Beck Mack Oliver Ltd Liability Com owns 68,339 shares for 0.35% of their portfolio. (NYSE:EDR). Landscape Capital Mngmt Ltd Liability Company, a New Jersey-based fund reported 64,800 shares. They expect $1.78 EPS, up 39.06% or $0.50 from last year's $1.28 per share. BGCP's profit will be $107.58 million for 11.63 P/E if the $0.30 EPS becomes a reality. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating, eight have issued a buy rating and two have given a strong buy rating to the company's stock. As per Friday, October 23, the company rating was maintained by UBS. On Thursday, October 19 the stock rating was maintained by Canaccord Genuity with "Hold". As per Friday, February 9, the company rating was maintained by Cowen & Co. Vetr raised shares of AbbVie from a "buy" rating to a "strong-buy" rating and set a $128.42 target price on the stock in a research note on Tuesday, March 6th. (NASDAQ:AAPL) earned "Buy" rating by Longbow on Wednesday, July 6. Mizuho maintained it with "Hold" rating and $15000 target in Friday, July 21 report. The firm has "Buy" rating given on Tuesday, July 19 by Drexel Hamilton.
Since January 1, 0001, it had 0 insider buys, and 1 sale for $200,678 activity.
Shelter Ins Retirement Plan decreased its stake in Abbvie Inc (ABBV) by 5.02% based on its latest 2017Q3 regulatory filing with the SEC. Therefore 48% are positive. Johnson & Johnson had 91 analyst reports since August 7, 2015 according to SRatingsIntel. The company was maintained on Friday, October 13 by Barclays Capital. The firm earned "Hold" rating on Sunday, July 30 by BMO Capital Markets. The rating was initiated by Leerink Swann with "Mkt Perform" on Tuesday, October 18. Goldman Sachs maintained Apple Inc. Deutsche Bank has "Hold" rating and $6 target. The stock has "Neutral" rating by Goldman Sachs on Monday, April 25. Piper Jaffray Companies restated a "buy" rating on shares of AbbVie in a research report on Tuesday, January 2nd. (NYSE:ABBV) rating on Monday, July 17. The company has a consensus rating of "Buy" and a consensus target price of $120.96.
Investors sentiment decreased to 0.8 in 2017 Q3. Its down 0.05, from 0.85 in 2017Q2.
MHI Funds LLC acquired a new stake in AbbVie Inc. (NYSE:ABBV) or 25,000 shares.
By digging out more, shifting focus on performance of the AbbVie Inc.
The company is expected to report earnings of $1.79 a share for the next quarter. Archford Strategies Ltd Liability reported 27,825 shares. Advent Capital De invested 0.01% of its portfolio in AbbVie Inc.
Alpha Cubed Investments Llc decreased Abbvie Inc (ABBV) stake by 47.13% reported in 2017Q3 SEC filing. Mufg Americas Holding Corp accumulated 0% or 560 shares. Fort Washington Advisors Oh stated it has 132,979 shares. About 30,199 shares traded. X Mngmt Com Lc has 23,397 shares. Brandywine Tru accumulated 161,371 shares. This repurchase authorization allows the company to buy shares of its stock through open market purchases. Braun Stacey Assocs holds 0.25% or 41,975 shares in its portfolio.
Since September 28, 2017, it had 0 insider purchases, and 13 insider sales for $49.94 million activity. Another trade for 8,280 shares valued at $976,084 was made by GONZALEZ RICHARD A on Wednesday, February 28. Garland Capital Management Inc.'s holdings in AbbVie were worth $5,725,000 as of its most recent filing with the Securities and Exchange Commission. Abbvie Inc had 79 analyst reports since July 21, 2015 according to SRatingsIntel.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.